-
Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors
Scholtes, R. A., van Baar, M. J. B., Kok, M. D., Bjornstad, P., Cherney, D. Z. I., Joles, J. A. & van Raalte, D. H., May 2021, In: Nephrology (Carlton, Vic.). 26, 5, p. 377-390 14 p.Research output: Contribution to journal › Review article* › Academic › peer-review
-
Natriuretic effect of two weeks of dapagliflozin treatment in patients with type 2 diabetes and preserved kidney function during standardized sodium intake: Results of the dapasalt trial
Scholtes, R. A., Muskiet, M. H. A., van Baar, M. J. B., Hesp, A. C., Greasley, P. J., Karlsson, C., Hammarstedt, A., Arya, N., van Raalte, D. H. & Heerspink, H. J. L., 1 Feb 2021, In: Diabetes care. 44, 2, p. 440-447 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Glucosuria Interferes With Measurement of Effective Renal Plasma Flow Using para-Aminohippuric Acid, With a Focus on SGLT2 Inhibitors
Scholtes, R. A., Nguyen, I. T. N., van Bommel, E. J. M., Willekes, N., van Nieuwenhuijzen, M., van Raalte, D. H. & Joles, J. A., 1 Nov 2020, In: Kidney International Reports. 5, 11, p. 2052-2054 3 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
